Viatris VTRS
NASDAQ VTRS
$16.32 +0.32 (+2.00%)
At close: Aug 21, 2026 · 4:00 PM EDT

Viatris (VTRS) Short-Term Debt issuances (2020 - 2025)

Viatris (VTRS) posted quarterly Short-Term Debt issuances of -$1.5 million for Q4 2025, little changed year-over-year from -$1.5 million in Q4 2024, and down 600.0% quarter-over-quarter from $300000.0 in Q3 2025.

Viatris (VTRS) Short-Term Debt issuances (2020 - 2025) Analysis & Trends

Viatris' Short-Term Debt issuances history runs 6 years deep, the most recent figure standing at -$1.5 million for Q4 2025.

  • In Q4 2025, Short-Term Debt issuances changed 0.0% year-over-year to -$1.5 million; the TTM figure through Mar 2026 stood at -$1.2 million (down 185.71% YoY), while the FY2025 annual figure was $200000.0, changed N/A from the prior year.
  • Short-Term Debt issuances for Q4 2025 stood at -$1.5 million, down from $300000.0 in the prior quarter.
  • The five-year high for Short-Term Debt issuances was $1.3 billion in Q2 2021, with the low at -$1.1 billion in Q1 2021.
  • The 5-year median for Short-Term Debt issuances is -$1.5 million (2024), against an average of -$64.7 million.
  • The sharpest annual moves came in 2023 and 2024: Short-Term Debt issuances jumped 124.42% in 2023, then tumbled 1600.0% in 2024.
  • Viatris' Short-Term Debt issuances stood at -$214.0 million in 2021, then slumped by 133.83% to -$500.4 million in 2022, then surged by 100.02% to $100000.0 in 2023, then sank by 1600.0% to -$1.5 million in 2024, then changed by 0.0% to -$1.5 million in 2025.
  • Business Quant data shows VTRS's Short-Term Debt issuances at -$1.5 million in Q4 2025, $300000.0 in Q3 2025, and $1.4 million in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Short-Term Debt issuances (Qtr)
1 Haleon 44.51 Bn 43.55 Bn - -
2 Teva Pharmaceutical Industries 43.52 Bn 39.86 Bn 2.15 Bn -
3 Zoetis 32.43 Bn 30.75 Bn 1.05 Bn -
4 Takeda Pharmaceutical 28.63 Bn 22.83 Bn 5.10 Bn -
5 United Therapeutics 21.87 Bn 19.21 Bn 683.80 Mn -
6 Viatris 18.98 Bn 18.09 Bn 1.46 Bn -
7 Neurocrine Biosciences 15.43 Bn 15.04 Bn 935.80 Mn -
8 Elanco Animal Health 12.02 Bn 11.49 Bn 798.00 Mn 50.00 Mn
9 Dr Reddys Laboratories 10.14 Bn 9.98 Bn - -
10 Alkermes 8.07 Bn 7.41 Bn 397.90 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 -1.50 Mn
Dec 31, 2025 -1.50 Mn
Sep 30, 2025 300,000.00
Sep 30, 2025 300,000.00
Mar 31, 2025 1.40 Mn
Mar 31, 2025 1.40 Mn
Dec 31, 2024 -1.50 Mn
Dec 31, 2024 -1.50 Mn
Sep 30, 2024 1.50 Mn
Sep 30, 2024 1.50 Mn
Dec 31, 2023 100,000.00
Dec 31, 2023 100,000.00
Sep 30, 2023 -22.90 Mn
Sep 30, 2023 -22.90 Mn
Jun 30, 2023 -181.50 Mn
Jun 30, 2023 -181.50 Mn
Mar 31, 2023 204.60 Mn
Mar 31, 2023 204.60 Mn
Dec 31, 2022 -500.40 Mn
Dec 31, 2022 -500.40 Mn